ORLY? Sorry to sound condescending but your glib comment shows an utter lack of awareness about discovering or designing novel drugs. It is never as simple as changing a line of code to get a new molecule that will kill the now resistant bugs and have no new adverse effects on the host.
Drug resistance is a huge problem today and threatens to grow bigger, where pathogens become resistant to drugs (known to be generally safe) and the arsenal of medicines is empty or has investigational drugs of unknown safety.
And what's the alternative? Don't attack the cells?
No. The alternative, in the short term, is to avoid indiscriminate use of drugs that still work, by testing the infecting bugs for pre-existing resistance markers and then using drugs that are orthogonal to co-evolving resistance mutations.
In the longer term, discovering wholly new classes of drugs, like this polymer, but testing for safety and adverse side-effects, is going to be our best hope. Again, the caveat against indiscriminate use applies.